BI 765845 / Boehringer Ingelheim - LARVOL DELTA

IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack (clinicaltrials.gov) - P2 | N=160 | Active, not recruiting | Sponsor: Boehringer Ingelheim | Trial completion date: Dec 2026 ➔ Dec 2025

Trial completion date • Cardiovascular • Myocardial Infarction

IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack (clinicaltrials.gov) - P2 | N=160 | Active, not recruiting | Sponsor: Boehringer Ingelheim | N=350 ➔ 160 | Trial completion date: Mar 2027 ➔ Dec 2026 | Trial primary completion date: Dec 2026 ➔ Sep 2025 | Recruiting ➔ Active, not recruiting

Enrollment change • Enrollment closed • Trial completion date • Trial primary completion date • Cardiovascular • Myocardial Infarction

A Study in Healthy Japanese Men to Test How Well Different Doses of BI 765845 Are Tolerated (clinicaltrials.gov) - P1 | N=32 | Completed | Sponsor: Boehringer Ingelheim | Active, not recruiting ➔ Completed

Trial completion

A Study to Test Whether BI 765845 Helps People Who Have Had an Acute Heart Attack (clinicaltrials.gov) - P2 | N=350 | Recruiting | Sponsor: Boehringer Ingelheim | Not yet recruiting ➔ Recruiting

Enrollment open • Cardiovascular • Myocardial Infarction